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Abstract
Background: Tuberculosis (TB) and human immune virus/acquired immune deficiency syndrome (HIV/AIDS)
stigmas affect public attitudes toward TB treatment and policy. This study examined ‘stigmatizing’ ideas and the
view that ‘TB patients should line-up in the chronic illness queue’ in relation to preferences and attitudes toward
TB treatment.
Methods: Data were gathered through a survey administered to respondents from 1,020 households in
Grahamstown. The survey measured stigmatization surrounding TB and HIV/AIDS, and determined perceptions of
respondents whether TB patients should queue with other chronically ill patients. Respondents selected support
and treatment options they felt would benefit TB patients. Statistical analysis identified the prevalence of TB and
HIV/AIDS stigmas. Logistic regression analyses explored associations between stigmatizing ideas, views regarding TB
patients in the chronic illness queue, and attitudes toward support and treatment.
Results: Respondents with TB stigmatizing ideas held positive attitudes toward volunteer support, special TB
queues, and treatment at clinics; they held negative attitudes toward temporary disability grants, provision of
information at work or school, and treatment at the TB hospital. Respondents who felt it beneficial for TB patients
to queue with other chronically ill patients conversely held positive attitudes toward provision of porridge and
disability grants, and treatment at the TB hospital; they held negative attitudes toward volunteer support, special
TB queues, information provision at work or school, and treatment at clinics.
Conclusion: These results showed that two varying views related to visibility factors that expose patients to
stigmatization (one characterized by TB stigma, the other by the view that TB patients should queue with other
chronically ill patients) are associated with opposing attitudes and preferences towards TB treatment. These
opposing attitudes complicate treatment outcomes, and suggest that complex behaviors must be taken into
account when designing health policy.
Background
Tuberculosis (TB) is a major cause of illness and death
worldwide, particularly in low- and middle-income
countries where it is fueled by human immune virus/
acquired immune deficiency syndrome (HIV/AIDS). TB
is the most common secondary infection for the
approximately 5.5 million South Africans living with
HIV/AIDS. About 700 per 100,000 of the national popu-
lation are infected with TB, classifying it as a serious
epidemic [1]. It is particularly endemic in the Eastern
Cape, a South African province characterized by high
levels of poverty and unemployment. Its cure rate of
41% is well below that recommended by the World
Health Organization (85%) [1,2]. WHO’s 2006 response
to 9.2 million new cases and 1.7 million TB-related
deaths worldwide was to launch a “Stop TB” strategy [1]
that built on the Directly Observed Treatment Short
Course (DOTS) launched in 1995. More than 22 million
patients have been treated under DOTS-based services
[3] but the results seem to lag behind their aim [1,2,4].
Disease-related stigmas negatively influence treatment,
including that of TB [5-7]. TB stigmatization is
* Correspondence: cramm@bmg.eur.nl
Institute of Health Policy and Management, Erasmus University Rotterdam, P.
O. Box 1738, 3000 DR Rotterdam, the Netherlands
Cramm and Nieboer International Journal for Equity in Health 2011, 10:2
http://www.equityhealthj.com/content/10/1/2
© 2011 Cramm and Nieboer; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
interesting in that the initial social shunning was largely
eliminated with a TB cure, but stigmas re-emerged
when it became a marker for HIV/AIDS [7-9]. The
effect was amplified when the cost effective combination
of TB and HIV/AIDS treatment was chosen as a recom-
mended strategy [3,9]. Disease-related stigmas also nega-
tively affect public attitudes toward prevention, service
provision, and health-related policies. A study on stig-
mas has indicated that people with less stigmatizing
ideas were significantly more favorably responsive to
disease-related governmental policies [10]. Availability of
treatment, however, does not necessarily translate to
seeking or adhering to it. The Botswanan government,
for example, recently began offering a free, widely publi-
cized, and easily accessible antiretroviral (ARV) treat-
ment to all citizens with AIDS but only 15% of eligible
citizens took part in the program [11]. Different views
related to visibility factors that expose patients to stig-
matization may lead to varying attitudes and preferences
towards TB treatment. In a qualitative study on TB
stigma in South Africa Møller & Erstad (2007) found
that visibility factors around TB treatment provision are
related to stigma. In South African townships there are
often long waiting queues at the clinics and TB patients
mention having problems with presenting at the TB
clinics for treatment because they want to avoid being
seen in a TB queue. In addition, their study findings
indicate that hospitalization in the local TB hospital,
and arrangements in health clinics that group HIV/
AIDS and TB together, have become markers of stigma.
As a result to avoid being stigmatized, people reportedly
avoided any behavior that might identify them as being
infected with TB or AIDS. Persons with TB symptoms
were tempted to ‘hide’ their status, for example, people
avoided joining queues and entering rooms reserved for
AIDS patients in clinics and people were reluctant to be
admitted to the local TB hospital [7]. Thus, TB- and
HIV/AIDS-associated stigmas influence both attitudes
and behavior toward treatment. The persistence of
HIV- and TB-related stigmatization - antiretroviral med-
ications and TB treatment programs notwithstanding -
reminds us that efforts to reduce it must be renewed.
An intervention that recasts TB and HIV as chronic
manageable conditions [12] may be one such effort.
Although research indicates that public attitudes and
health care policy responses are strongly influenced by
perceptions of illness [6] and that others’ attitudes influ-
ence how individuals define and act upon symptoms
and life crises [13], it remains unclear how disease-
related stigmas affect treatment access and compliance.
Since the Eastern Cape has a high incidence/prevalence
of TB and one of the worst cure rates in South Africa,
its inhabitants can be considered experienced in relating
to TB. In this study, we thus seek to identify the
pervasiveness of TB and HIV/AIDS stigmas, as well as
attitudes toward treatment. We also investigate the rela-
tionship between two views, one characterized by stig-
matization and the other (more non-stigmatizing view)
that TB patients should queue with other chronically ill
patients. Understanding of the relationship between
(stigmatizing) views and lay public TB treatment prefer-
ences may be helpful to TB program design and better
treatment outcomes.
Methods
The Eastern Cape is a South African province character-
ized by high levels of poverty, unemployment and where
TB is endemic [7]. We used data from a November,
2007 survey of 1,020 Grahamstown East/Rhini house-
holds. The median age of respondents was 38 and
almost three quarters (73%) were women. Just over half
were single (52%), a third married (33%) and the others
widowed (9%) or separated/divorced (6%). Forty percent
had completed some secondary education and 18% had
matriculated. Approximately 7% had received post-
matriculation education and training. Only 8% had no
formal schooling.
TB prevalence was assessed by a dichotomised lifetime
tuberculosis item that stated, ‘There has been a case of
TB in this household’. We did not assess individual-level
experience with TB because the interview was held face-
to-face; given the stigmatisation of TB, we felt that
respondents might not answer such questions truthfully.
About one third (32.3%) of respondents claimed to
(had) have a TB case in the household in accordance
with TB prevalence statistics [3].
Ethical approval
This study was approved by the Rhodes University Ethi-
cal Standards Committee. All personal identifiers have
been removed or disguised such that the person(s) are
not identifiable.
Subjects and sampling design
An area-stratified sampling design was applied. House-
holds in the 23 neighborhoods of Rhini, a suburb of
Grahamstown, were randomly selected in proportion to
the total number of households in each neighborhood.
Moving systematically through each neighborhood from
a random starting point, every tenth household was
included in the sample. All households in all areas of
Rhini thus had an equal probability of survey inclusion.
Eligible respondents were over 17 years old and had
resided in Rhini for at least 6 months in the past year.
One respondent per household was chosen using a Kish
grid to ensure that all eligible persons in the household
had an equal probability of survey inclusion. Identified
respondents were interviewed immediately if they
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consented or arrangements were made to conduct the
interview later. Up to four visits to the house were
made to interview respondents who were initially absent.
Interviews were obtained in 1,020 of the 1,042 house-
holds (97.9%). The 22 respondents dropped from
the sample either (1) could not be contacted by the
fourth visit to the house, or were (2) too old, (3) too ill,
or (4) unwilling.
Trained Development Research Africa and local inter-
viewers conducted the interviews. Nearly all questions
were closed-ended items for which a set of response
options was supplied. A detailed description of the study
population can be found in the Institute of Social and
Economic Research, Research Report Series No. 14 &
No. 15 [14,15].
Instruments
We have good reason to believe that the concepts
underlying the previously developed AIDS-related
stigma scale (e.g., stained social identity, blame, shame-
fulness, avoidance, social sanction) apply to stigmatiza-
tion of TB patients as well. The brief nine-item scale
has been tested in several South African communities, is
internally consistent and reliable, and has a Cronbach’s
alpha (a) of 0.75 [16]. One item exhibiting a low corre-
lation with the total score that reduced the internal
consistency of the scale was discarded. The resulting
eight-item AIDS-related stigma scale was used to assess
the stigmatizing ideas of respondents regarding HIV
(Cronbach’s a of 0.77) and TB (Cronbach’s a of 0.74).
Respondents could either agree or disagree with each
item (appendix). We calculated TB stigma and HIV
stigma using count scores of correct answers (range
0-8). We also added a statement concerning visibility:
Would TB patients stay on treatment if they could
queue together with chronic disease patients?
In the Eastern Cape, TB treatment can be obtained at
a TB hospital, a clinic, or at home. In the case of home
care, either a family member or a DOTS volunteer pro-
vides medicine daily. Visibility, or TB identifiability, is
an important factor with respect to stigmatization; the
survey thus asked respondents to state preferences for
treatment location and medicine delivery mode.
Most surveys of lay public attitudes use a rating
approach [17] in which all items are equally important
and therefore lack the prioritizing that would facilitate
treatment decisions [18]. Here, we opted for the more
realistic priority setting with a ranking approach [17,19].
A 2006 focus group identified five TB treatment sup-
port types available in the Rhini area [7]. TB patients
can be paired with a DOTS volunteer for support; food
assistance in the form of porridge can be provided,
which ensures that medication is not taken on an empty
stomach; special queues or rooms are made available at
some clinics to reduce waiting time for TB patients who
collect medication themselves; TB patients are provided
a temporary disability grant, ensuring financial indepen-
dence while on treatment; and volunteers will inform
TB patients’ employers or schools that the disease is not
infectious when it is being treated. Respondents were
asked to select up to two support types felt to be the
most helpful to patients and their families.
Data Analysis
The analysis consisted of three parts. To determine the
level of stigmatizing ideas and test the view that TB
treatment should be integrated with chronic illnesses we
first used a descriptive analysis to characterize the pre-
valence of the views. Second, we performed a logistic
regression analysis to test whether stigmatizing ideas
and the view of queuing TB patients together with
chronically ill patients are associated with different atti-
tudes and preferences toward TB treatment and support
types (it does not help to put TB patients in a queue
with other chronically ill patients = 0; it does help to
put TB patients in a queue with other chronically ill
patients = 1). We dichotomized stigma for use in the
logistic regression analysis into scores of 0 versus scores
of > 0 (not stigmatizing ideas = 0; stigmatizing ideas = 1).
Because stigma was an index based on the number of
correct answers, we dichotomized it to conduct logistic
regression analyses rather than multivariate analyses and
scale scores. For regression analyses, we reported odd
ratio (OR) values. Last, correlation and logistic regression
analyses were performed to test whether differences in
TB experience, age, gender, marital status and education
are associated with different attitudes and preferences
toward TB treatment and treatment assistance types.
Significant variables from the correlation analyses were
entered into the logistic regression model.
Results
The prevalence of stigmatizing ideas regarding HIV/
AIDS in this community was higher (mean 0.93) than
that of stigmatizing ideas surrounding TB (mean 0.52).
Pearson correlations for stigmatizing ideas of TB and
HIV/AIDS revealed a relation (r = 0.66; p ≤ 0.001). Of
the 1,020 respondents, 70% believed it would be benefi-
cial to have TB patients queuing with chronic diseases.
When we look at the respondents who agree or disagree
with the belief that it would be beneficial to have TB
patients queuing with chronic diseases, we found that
they differ on the TB stigma scale. Respondents who felt
it would be beneficial to have TB patients queuing with
chronic diseases held less stigmatizing views toward TB
patients. They did not differ on HIV stigma.
Logistic regression analyses examined whether stigma-
tizing ideas and/or the view that TB patients should be
Cramm and Nieboer International Journal for Equity in Health 2011, 10:2
http://www.equityhealthj.com/content/10/1/2
Page 3 of 7
queuing with other chronically ill patients are associated
with different attitudes toward support and treatment
preferences. No significant relations were found between
HIV/AIDS stigmas and attitudes toward support and
treatment preferences. TB stigmatizing ideas were signif-
icantly associated with a negative attitude toward pro-
viding TB patients disability grants and allaying fears of
contagion at work or school; they were significantly
related to a positive attitude toward DOTS volunteers
and special queues for TB patients at the clinics. The
view that TB patients would benefit from queuing with
other chronically ill patients was associated with a posi-
tive attitude toward food assistance and disability grants.
It revealed a negative attitude toward support from
DOTS volunteers and providing information about non-
contagiousness to employer or school (table 1).
Lay public attitudes indicated that TB stigmatizing
ideas are related to a positive attitude toward treatment
at clinics and a negative attitude toward treatment at
the TB hospital. The view that TB patients should be
queuing with the chronically ill predicted the opposite: a
positive attitude toward TB treatment at the hospital
and a negative attitude toward treatment at the clinics
(table 2).
Correlation and logistic regression analyses were per-
formed to test for different attitudes and preferences
toward TB treatment and treatment assistance types in
households with and without TB experience. About
one third (32.3%) of respondents claimed to have (had)
a TB case in the household. Correlation analyses
revealed that only gender and education are associated
with TB treatment and treatment assistance types. We
found no significant differences in outcomes with age,
marital status and households with and without TB
experience. When we entered gender and education
into the logistic regression models we only found an
association between education and contacting people
at work or school to inform them that the patient is
not infectious because he/she is on treatment. Higher
educated held a more positive attitude toward this type
of assistance. Data are not presented but information
is available on request.
Discussion
We investigated lay perceptions on TB treatment in the
Eastern Cape and tried to identify the pervasiveness of
stigmas and the relationships between (stigmatizing)
ideas and TB treatment attitudes and preferences.
Because this area has a high incidence/prevalence of TB
and one of the worst cure rates of South Africa [1,2], its
inhabitants can be considered experts when it comes to
matters concerning TB. Our study results are thus rele-
vant to possible improvement of treatment outcomes.
The most salient aspect of the study is that two views
(one characterized by TB stigma, the other by the view
that TB patients should queue with other chronically ill
patients) are associated with opposite attitudes and pre-
ferences towards TB treatment.
Table 1 Logistic regression analyses of TB treatment assistance preferences and TB stigmatizing ideas, HIV/AIDS
stigmatizing ideas and the view that TB patients should be queued with other chronically ill patients
Assigning a DOTS
volunteer to
support them
while on
treatment
Providing porridge so
TB patients do not
take their medicine on
an empty stomach
Assigning
special
queues or a
special room
at clinics
Giving TB patients a
temporary disability grant so
they can be financially
independent while on
treatment
Contacting people at work or
school to inform them that the
patient is not infectious
because he/she is on treatment
Adjusted OR Adjusted OR Adjusted OR Adjusted OR Adjusted OR
TB stigma 1.230
(1.084-1.449)
1.075 (0.933-1.225) 1.169
(1.000-1.354)
0.708 (0.600-0.826) 0.852 (0.671-1.009)
HIV/AIDS
Stigma
1.122 (0.992-1.316) 0.975 (0.828-1.104) 0.960
(0.838-1.120)
0.982 (0.831-1.109) 0.937 (0.786-1.132)
TB patients
queued with
chronically ill
0.756
(0.583-0.974)
1.442 (1.094-1.879) 0.873
(0.660-1.177)
1.667 (1.283-2.083) 0.710 (0.517-0.971)
Constant 0.950 1.161 0.364 0.508 0.415
Model c2 x2 = 22.443 x2 = 8.062 x2 = 5.295 x2 = 42.181 x2 = 8.475
-2 log
likelihood
1381,757 1308.976 1126.231 1361.622 984.000
Nagelkerke R2 0.029 0.011 0.008 0.054 0.013
Notes: Figures in bold are statistically significant at p < 0.05.
Not stigmatizing ideas = 0; stigmatizing ideas = 1.
It does not help to put TB patients in a queue with other chronically ill patients = 0; it does help to put TB patients in a queue with other chronically ill patients = 1.
The tables stating the logistic regression models also adjust for gender and education.
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Opposing attitudes and preferences toward TB treatment
In this study HIV stigmatizing ideas showed no signifi-
cant attitudes in relation with attitudes and preferences
toward TB treatment in addition to TB stigmatizing
ideas, probably because the correlation analysis revealed
that the stigmas are related to each other. Other
research has also shown how visible signs of TB trigger
HIV stigmatization and even claim that a new disease
stigma has emerged, namely the TB-HIV stigma [8]. TB
stigmatizing ideas were associated with positive attitudes
toward treatment at the clinic and negative attitudes
toward treatment at the hospital, the opposite was asso-
ciated with the preference to queue TB patients with
other chronically ill individuals.
Theoretically, all TB patients are assigned a treatment
supervisor. His or her role at the hospital and clinics is
minimal, however, compared to that of family members
or volunteers who distribute medicine. TB patients who
personally collect their medication at a hospital or clinic
may be identified as TB- or HIV/AIDS-infected (and
therefore stigmatized), especially when TB and HIV/
AIDS treatments are combined. Home visits from a
DOTS volunteer also increases neighborhood awareness
of the presence of TB in the household and conse-
quently may lead to stigmatizing, which, in turn, has
repercussion on TB treatment. Our results showed that
respondents with TB stigmatizing ideas or the view that
TB patients should queue with other chronically ill
patients indeed are associated with different attitudes
toward TB treatment. There seems to be no single solu-
tion. Combined TB and HIV/AIDS treatment presents
another problem. Some views of the lay public (e.g.,
views regarding combined or separate TB queues) might
lead to negative attitudes toward combined TB
and HIV/AIDS treatment, resulting in a disincentive to
seek treatment [20]. Such varying attitudes could explain
the Botswanan example, where only 15% of citizens
with AIDS participated in the free ARV treatment
program [11].
Opposing attitudes and preferences toward
TB treatment assistance
For other assistance types, the two views relate to con-
trasting attitudes. While TB stigmatizing ideas are
related to a positive attitude toward assigning DOTS
volunteers, the view that TB patients should queue with
the chronically ill is associated with a negative attitude
toward DOTS volunteers. The view that TB patients
should queue with the chronically ill is related to a posi-
tive attitude only in providing food assistance. TB-
stigmatizing ideas are related to a positive attitude only
in having special queues for TB patients. With respect
to providing disability grants, TB-stigmatizing ideas
show a negative attitude and those with the view that
TB patients should queue with the chronically ill have a
positive attitude.
There is unanimity of opinion on only one item: nega-
tive attitudes toward providing information at the
patient’s workplace or school were associated with both
TB-stigmatizing ideas and the view that TB patients
should queue with the chronically ill except for the
higher educated. However, this agreement could be
based on different reasons. People with TB-stigmatizing
views may think that this type of assistance does not
help, because TB patients have to help themselves and
people with the view that TB patients should queue
with the chronically ill might feel that TB patients do
not wish to be recognized as TB patient. The view that
TB patients benefit from being included with the
chronically ill is related to positive attitudes toward
Table 2 Logistic regression analyses of TB treatment preferences and TB stigmatizing ideas, HIV/AIDS stigmatizing
ideas and the view that TB patients should be queued up with other chronically ill patients
TB hospital Clinic Family member collecting
medicine
DOTS volunteer collecting
medicine
Adjusted OR Adjusted OR Adjusted OR Adjusted OR
TB stigma 0.784
(0.657-0.899)
1.326
(1.153-1.537)
1.030 (0.838-1.294) 0.841 (0.684-1.056)
HIV/AIDS Stigma 1.122
(0.957-1.276)
0.975
(0.836-1.121)
0.966 (0.778-1.214) 0.859 (0.712-1.058)
TB patients queued with
chronically ill
1.135
(0.997-1.267)
0.950
(0.825-1.082)
0.772 (0.522-1.130) 0.869 (0.630-1.210)
Constant 0.339 0.643 0.167 0.289
Model c2 x2 = 26.003 x2 = 21.687 x2 = 1.817 x2 = 7.646
-2 log likelihood 1340.191 1275.412 687.333 901.778
Nagelkerke R2 0.034 0.029 0.004 0.013
Notes: Figures in bold are statistically significant at p < 0.05.
Not stigmatizing ideas = 0; stigmatizing ideas = 1.
It does not help to put TB patients in a queue with other chronically ill patients = 0; it does help to put TB patients in a queue with other chronically ill patients.
The tables stating the logistic regression models also adjust for gender and education.
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supporting financial assistance. Providing porridge is a
less obvious form of financial assistance than disability
grants, but it alleviates a burden for both the TB patient
and the family. Food is an immediate benefit and saves
the family money. People with the combined-queuing
view preferred financial assistance through porridge and
grants rather than the more controlled assistance types
such as DOTS volunteers, whose home visits may iden-
tify an individual as a TB patient. This may also be the
main reason for preferring that TB patients be in the
same line as the chronically ill. Chronic diseases are
usually not associated with stigma; the visibility of seek-
ing treatment for a chronic illness therefore was not
associated with negative attitudes among respondents
with this view.
The TB stigmatizing view also is related to contrasting
attitudes toward TB treatment assistance. While those
who favor combined queues for TB and other chroni-
cally ill patients found financial assistance types helpful,
those with TB stigmatizing ideas had negative attitudes
toward disability grants. People with stigmatizing ideas
might blame TB patients for their illness and therefore
believe they do not deserve financial support. A positive
attitude was found between TB-stigmatizing ideas and
the controlled observation of treatment by a DOTS
volunteer. This view is related to preferences for visible-
stigma-sensitive assistance types and negative attitudes
toward financial assistance. Visibility of TB patients and
exposure to stigma were not important factors for peo-
ple with TB-stigmatizing ideas. They preferred separate
queues for TB patients and direct observation of treat-
ment by a DOTS volunteer. Results from a recent eva-
luation on effectiveness of TB treatment in four other
TB crisis areas in South Africa showed that the fewer
the patients allocated to DOTS volunteers, the higher
the cure rate [21]. The same might apply for these com-
munities. Visits from a DOTS volunteer lead to visible
exposure within the neighborhood. This could explain
the lower cure rates of the DOTS volunteer and suggest
that complex behaviors must be taken into account
when designing health policy.
Study limitations
Given the cross-sectional nature of the results, interpre-
tation of study results is restricted. Future research with
a longitudinal approach would be valuable. Our analyses
identified significant relations, but their relative strengths
were often weak. We found a relationship between visibi-
lity factors and attitudes and preferences toward TB
treatment but more research is necessary to include a lar-
ger set of visibility items. A major limitation is that our
research investigated perceptions of the lay public only;
behavior when faced with TB in a family member or
friend might be different. However, given the random
selection and inclusion of every tenth household, which
led to equal probability of survey inclusion of lay percep-
tions in the community, and the fact that households
with and without TB experience shared the same views
indicate that our study findings might represent the
actual situation. Since attitudes of the lay public play a
central role in the patient’s decision-making process it
would be interesting to conduct a follow-up study to gain
insight into whether and how disease stigmas actually
influence an individual’s attitudes and preferences toward
TB treatment and assistance.
Conclusions
Our results showed that two views related to visibility
factors that expose patients to stigmatization (one char-
acterized by TB stigma, the other by the view that TB
patients should queue with other chronically ill patients)
are associated with opposite attitudes and preferences
towards TB treatment. Visibility factors related to the
organization and delivery of treatment are also likely to
affect health-seeking behavior; some patients might seek
treatment at an earlier stage were it offered discreetly.
Solutions are neither easy nor clear-cut, especially when
considering highly-stigmatized diseases associated with
complex behaviors. Various strategies are probably
necessary to improve access and adherence to treatment
and thereby health outcomes.
Appendix 1
AIDS-related Stigma Scale
Please answer whether you agree or disagree with the fol-
lowing statements:
People who have AIDS are dirty
People who have AIDS are cursed
People who have AIDS should be ashamed
People with AIDS must expect some restrictions on
their freedom
A person with AIDS must have done something
wrong and deserves to be punished
People who have AIDS should be isolated
I do not want to be friends with someone who has
AIDS
People who have AIDS should not be allowed to work
TB-related Stigma Scale
Please answer whether you agree or disagree with the fol-
lowing statements:
People who have TB are dirty
People who have TB are cursed
People who have TB should be ashamed
People with TB must expect some restrictions on their
freedom
A person with TB must have done something wrong
and deserves to be punished
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People who have TB should be isolated
I do not want to be friends with someone who has TB
People who have TB should not be allowed to work
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